Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019

S. 2740 · 116th Congress · Dec 11, 2019 · Lineage

AN ACT

To amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.

1. Short title; table of contents

(a)

Short title— This Act may be cited as the “Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019”.

(b)

Table of contents— The table of contents for this Act is as follows:

Lineage

Dec 11, 2019viewing Referred in House Referred to the Committee on Energy and Commerce See what changed
Dec 10, 2019 Engrossed in Senate See what changed
Oct 30, 2019 Reported in Senate Mr. Isakson (for himself, Mr. Casey, and Mr. Braun) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions See what changed
Oct 30, 2019 Introduced in Senate Mr. Isakson (for himself and Mr. Casey) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019

1. Short title; table of contents

Cite this provision

Incoming references